Abstract
Background
Constipation is a prevalent functional gastrointestinal disorder that impairs quality of life and is frequently accompanied by psychological distress. Emerging evidence suggests a potential association between constipation and depression, possibly mediated by gut–brain axis dysfunction; however, epidemiological findings remain inconsistent.
Methods
We conducted a systematic review and meta-analysis of observational studies examining the association between constipation and depression in the general population. PubMed, Web of Science, Embase, and the Cochrane Library were searched from inception to October 1, 2025. Random-effects models were used to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity, prediction intervals, subgroup analyses, sensitivity analyses, and publication bias were assessed.
Results
Eighteen studies involving 730,263 participants were included. Constipation was significantly associated with an increased risk of depression (OR = 2.08, 95% CI: 1.84–2.34), with substantial heterogeneity (I² = 92.6%). The association remained robust across sensitivity analyses. Stronger associations were observed in adolescents, in studies conducted in Asia and North America, in smaller studies, and in those using self-reported depression measures. Prediction interval analyses indicated a consistently positive association across diverse populations.
Conclusions
This meta-analysis provides robust evidence that constipation is associated with a significantly increased risk of depression. These findings highlight the importance of integrated gastrointestinal and mental health care, particularly for younger individuals with chronic constipation, and support further prospective and mechanistic studies targeting the gut–brain axis.
Subject terms: Depression, Predictive markers
Introduction
Depression is one of the most prevalent and disabling mental disorders worldwide and is a major contributor to global disease burden and mortality [1]. Recent estimates suggest that approximately 350 million people are affected globally, with prevalence continuing to rise across diverse populations [2]. Depression increases the risk of suicidal ideation, suicide attempts, and premature death, and remains a leading cause of disability worldwide [3]. In addition to its core psychiatric symptoms, depression markedly impairs quality of life (QOL), worsens physical comorbidities, and imposes a substantial socioeconomic burden on individuals and healthcare systems [4–6]. Despite extensive research, its etiology remains multifactorial and incompletely understood, highlighting the need to identify modifiable risk factors and comorbid conditions that may contribute to its onset and progression.
Chronic constipation is among the most common functional gastrointestinal (GI) disorders and is typically characterized by infrequent bowel movements, difficult or painful defecation, and a sensation of incomplete evacuation [7, 8]. Its prevalence varies across populations but is generally high, particularly among adults and older individuals. Constipation not only causes persistent physical discomfort but also disrupts daily functioning, psychological well-being, and social participation, leading to increased healthcare utilization and reduced QOL [9–12]. Accumulating clinical evidence further suggests that constipation is frequently accompanied by psychological distress, raising the possibility of a clinically meaningful association with depression [13].
One biologically plausible framework linking constipation and depression is the gut–brain axis, a bidirectional communication network that integrates neural, immune, endocrine, and metabolic pathways between the GI tract and the central nervous system [14–19]. Disturbances in gut function and intestinal homeostasis may influence emotional regulation and cognitive processes, whereas psychological stress and mood disorders may in turn affect GI motility and secretion [20–22]. Consistent with this concept, dysregulation of the gut–brain axis has increasingly been implicated in both functional GI disorders and mood disorders, particularly depression [23–26]. Clinical observations also indicate that individuals with functional bowel disorders frequently exhibit comorbid depressive symptoms, supporting the presence of shared or interacting pathophysiological mechanisms [25, 27–29]. Importantly, however, the relationship between constipation and depression may be bidirectional: constipation-related disturbances in gut function may contribute to depressive symptoms, whereas depression itself may also promote constipation through behavioral changes, altered diet, reduced physical activity, autonomic dysregulation, and neuroendocrine pathways.
Alterations in the gut microbiota represent one potential mechanism underlying the coexistence of constipation and depression. Constipation has been associated with reduced microbial diversity and compositional shifts in gut bacterial communities, which may disrupt the production of neuroactive metabolites, promote low-grade systemic inflammation, and impair intestinal barrier integrity [30–33]. These microbiota-related changes may, in turn, influence brain function and behavior through immune signaling, microbial metabolites, and vagal pathways within the gut–brain axis [17]. At the same time, observed epidemiological associations may also reflect shared behavioral and lifestyle determinants rather than a unidirectional causal pathway. In particular, diet quality and related lifestyle factors may represent important sources of residual confounding, because poor dietary patterns are associated with depressive symptoms and may also contribute to constipation, especially in younger populations [34–36]. However, epidemiological studies examining this association have yielded inconsistent findings, likely owing to differences in study design, population characteristics, diagnostic criteria, and covariate adjustment [37, 38].
To date, no comprehensive systematic review and meta-analysis has quantitatively synthesized the available observational evidence on the association between constipation and depression. A rigorous quantitative synthesis is therefore needed to reconcile inconsistent findings, provide a pooled estimate of the strength of association, and identify potential sources of heterogeneity across studies.
In this study, we conducted a systematic review and meta-analysis of observational studies to evaluate the association between constipation and depression. The primary objective was to quantify this association by calculating pooled odds ratios (ORs), while secondary objectives were to explore sources of heterogeneity through subgroup and sensitivity analyses and to assess the overall quality of the evidence. Given the predominance of cross-sectional evidence in this field, our aim was to synthesize the available data on the association rather than to infer temporal direction or causality. By clarifying the magnitude and consistency of this association, our findings may have important translational implications for clinical practice, including the early identification of individuals with chronic constipation who may be more likely to experience co-occurring depressive symptoms. Moreover, a clearer understanding of this association may support more integrated clinical assessment of gastrointestinal and mental health symptoms and may help inform future prospective and mechanistic studies of potential shared pathways, including microbiota-related and gut–brain signaling mechanisms. Ultimately, this work provides an epidemiological foundation for future prospective, mechanistic, and interventional studies aimed at determining whether the gut–brain axis represents a clinically relevant pathway underlying the observed association.
Methods
Search strategy
This systematic review and meta-analysis was registered in the PROSPERO database (CRD420250610587) and conducted in accordance with the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
A comprehensive literature search was performed in four electronic databases—PubMed, Web of Science, Embase, and the Cochrane Library—from inception to October 1, 2025. The search strategy combined terms related to constipation and depression, including “constipation,” “bowel dysfunction,” and “slow transit,” together with “depression,” “depressive disorder,” and “mood disorder*,” to identify epidemiological surveys and population-based observational studies examining the association between constipation and depression. Detailed search strategies for each database are provided in the Supplementary Materials.
All retrieved records were screened independently by two reviewers (ZYR and ZYG), first by title and abstract and subsequently by full-text review to assess eligibility. Any discrepancies between reviewers were resolved through discussion, and when consensus could not be reached, a third reviewer with extensive experience in meta-analysis adjudicated the disagreement.
Eligibility criteria
Eligible studies were observational investigations, including cohort and cross-sectional studies, conducted in the general population. We focused on studies examining the association between constipation and depression in community-based or population-based samples. Studies conducted in selected clinical populations in which constipation was secondary to other conditions were excluded, such as patients with irritable bowel syndrome in whom constipation is a defining feature, or cancer patients experiencing opioid-induced constipation.
Studies were excluded if they met any of the following criteria: (1) they were reviews, conference proceedings, editorials, lectures, or abstracts without full-text data; (2) they lacked relevant data, had incomplete outcome information, or did not meet the predefined eligibility criteria regarding study design, population, exposure, or outcome; or (3) they were animal studies or basic experimental research.
Data extraction
Data extraction was performed independently by two reviewers using standardized extraction forms developed in Microsoft Excel 2021 (Microsoft, Redmond, WA). In accordance with established methodological recommendations for systematic reviews and meta-analyses [39], we extracted key study characteristics, including first author, year of publication, country, study design, and sample size. Participant characteristics were also collected, including age, sex distribution, and source of the study population.
In addition, we extracted core analytical data, including the methods used to assess constipation and depression, reported effect estimates (odds ratios [ORs]), and corresponding 95% confidence intervals (CIs). Any discrepancies in data extraction were resolved through discussion between the two reviewers, with arbitration by a third reviewer when necessary.
Outcome measures
The primary outcome of this systematic review was the presence of depression among individuals with and without constipation. Depression was defined according to the original criteria used in each included study. These definitions encompassed clinically diagnosed depression based on International Classification of Diseases (ICD) or Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria, physician-documented diagnoses obtained from medical records, or depressive symptoms assessed using validated self-report screening instruments, such as the Patient Health Questionnaire-9 (PHQ-9), Beck Depression Inventory (BDI), and Center for Epidemiologic Studies Depression Scale (CES-D), applying study-specific cutoff values.
Constipation was similarly defined based on each study’s assessment methods, including established clinical diagnostic criteria (e.g., Rome III or Rome IV), physician-documented diagnoses, or self-reported constipation symptoms. For the purposes of meta-analysis, all reported effect estimates were extracted or converted into odds ratios (ORs) with corresponding 95% confidence intervals (CIs), comparing the odds of depression in participants with constipation versus those without. Potential heterogeneity arising from differences in the assessment methods for constipation and depression was examined through predefined subgroup analyses.
Quality assessment
The methodological quality of the included studies was independently assessed by two reviewers using the Newcastle–Ottawa Scale (NOS), which evaluates study quality across selection, comparability, and outcome (or exposure) domains, with total scores ranging from 0 to 9. The quality assessment was performed after study selection and was used to characterize the methodological quality of the included studies; it was not used as an independent criterion for study exclusion. Studies were categorized as high quality (7–9), moderate quality (4–6), or low quality (0–3) [40]. Any discrepancies in quality assessment were resolved through discussion, and when necessary, by consultation with a third reviewer.
Statistical analysis
Pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated using random-effects models to account for both within-study and between-study variability. Between-study variance (τ²) was estimated using the restricted maximum likelihood (REML) method, and the Hartung–Knapp–Sidik–Jonkman (HKSJ) adjustment was applied to obtain more robust confidence intervals.
For studies reporting alternative effect measures, effect sizes were transformed to log odds ratios (ln ORs) to allow inclusion in the pooled analysis. Specifically, standardized mean differences (SMDs) were converted to ln ORs using the logistic approximation [41]:
Correlation coefficients (r) were treated as approximate standardized effects and transformed using the same logistic function [42]. Hazard ratios (HRs) and risk ratios (RRs) were considered reasonable approximations of ORs under the assumption of a relatively low incidence of depression. Sensitivity analyses were conducted to evaluate the potential impact of these approximations on the pooled estimates.
Statistical heterogeneity was assessed using both τ² and the I² statistic. In addition to pooled effect estimates, 95% prediction intervals were calculated to estimate the expected range of effects in future populations. Sensitivity analyses included leave-one-out analyses and exclusion of studies with converted effect sizes to assess the robustness of the findings. Publication bias was evaluated visually using funnel plots and statistically using Egger’s regression test. All statistical analyses and graphical outputs were performed using Stata version 17 (StataCorp, College Station, TX). A two-sided p value < 0.05 was considered statistically significant.
Subgroup analysis
Predefined subgroup analyses were conducted to explore potential sources of heterogeneity in the association between constipation and depression. Subgroups were defined a priori based on demographic characteristics, including geographic region, sex, and age, as well as methodological factors, such as study design, sample size, and assessment tools used to define constipation and depression. Subgroup-specific pooled ORs were calculated using the same random-effects modeling approach as in the primary analysis. Differences between subgroups were formally examined using meta-regression analyses.
Results
Search results
A total of 8153 records were identified through searches of four electronic databases, of which 3336 duplicates were removed. The remaining records were screened independently by two reviewers based on titles and abstracts, resulting in the exclusion of articles that were clearly irrelevant to the study objectives. Following this initial screening, 57 articles were retrieved for full-text assessment. Of these, 43 were excluded for the following reasons: studies in clinical populations (n = 39), review/editorial/conference abstract without eligible full-text data (n = 2), irrelevant exposure or outcome (n = 1) and animal/basic experimental research (n = 1).
After detailed evaluation of the full-text articles, 14 studies met the predefined eligibility criteria and were included in the meta-analysis. In addition, during the full-text review process, four additional potentially relevant studies were identified through manual reference screening that had not been captured in the initial database search. All four studies fulfilled the inclusion criteria and were therefore included. Consequently, a total of 18 studies were incorporated into the final qualitative and quantitative analyses. The study selection process is illustrated in Fig. 1.
Fig. 1. Flow diagram of study identification, screening, eligibility assessment, and inclusion in the systematic review and meta-analysis.
The diagram outlines the literature search strategy, numbers of records identified from databases, records screened, full-text articles assessed for eligibility, and studies included in the final quantitative synthesis, with reasons for exclusion at each stage.
Basic characteristics and quality assessment of included studies
A total of 18 observational studies, encompassing 730,263 participants, were included in the analysis. The key characteristics of these studies are summarized in Table 1. The studies were conducted across multiple geographic regions, including North America (n = 9), Asia (n = 6), Europe (n = 2), and Oceania (n = 1). Most studies employed a cross-sectional design (15 of 18), while three were cohort studies.
Table 1.
Characteristics of studies included.
| Author | Year | Country | Study type | Sample size | Female ratio (%) | Age range | Assessment of constipation | Assessment of depression | NOS score |
|---|---|---|---|---|---|---|---|---|---|
| Adibi P [37] | 2022 | Iran | Cross-sectional | 3362 | 58.5 | 36.3 ± 7.9 years | Rome III | HADS-D | 9 |
| Cheng C [74] | 2003 | Hong Kong | Cross-sectional | 3282 | N | N | Rome II | HADS-D | 7 |
| Eustis SJ [75] | 2022 | USA | Cross-sectional | 5245 | 51.0 | 46.32 ± 0.25 years | Self-report | PHQ-9 | 8 |
| Haug TT [76] | 2002 | Norway | Cross-sectional | 60998 | About 50% | all adults aged 20 and above | Clinical diagnostic | HADS-D | 8 |
| He Z [38] | 2024 | USA | Cross-sectional | 11760 | 48.9 |
20–39 y: 32.4% 40–59 y: 32.3% 60–79 y: 25.8% 80+y: 9.6% |
BSFS | PHQ-9 | 9 |
| Huang Q [77] | 2025 | USA | Cross-sectional | 12854 | 51.9 | 49.93 ± 17.95 years | Clinical diagnostic | PHQ-9 | 9 |
| Jiang B-C [78] | 2025 | China | Cross-sectional | 12721 | 51.3 | 61.9 year | Rome IV | PHQ-9 | 8 |
| Kiko H [79] | 2025 | Japan | Cross-sectional | 984 | 56.6 | 78.1 ± 6.1 years | CSS | GDS-15 | 5 |
| Mody R [80] | 2014 | USA | Cohort | 115416 | 66.7 | 49.6 ± 17.7 years | ICD-9 | ICD-9 | 8 |
| Rajindrajith S [81] | 2020 | Sri Lanka | Cross-sectional | 913 | N | 13-18 years | Rome III | CBCL | 7 |
| Sun Z [82] | 2022 | China | Cohort | 1678 | 71.5 | 19.63 ± 1.20 years | Questionnaire report | GDS-15 | 7 |
| Vu NTH [83] | 2024 | Japan | Cross-sectional | 5386 | 46.1 | 21.1 ± 4.1 years | Rome IV | BDI | 8 |
| Wang L [84] | 2024 | USA | Cross-sectional | 13820 | 51.5 | all ages over 20 | Clinical diagnostic | PHQ-9 | 9 |
| Wang P [85] | 2023 | USA | Cross-sectional | 12352 | 49.7 | 49.3 ± 17.7 years | Self-reported | PHQ-9 | 9 |
| Wang P [86] | 2025 | USA | Cross-sectional | 13493 | 49.5 | 49.2 ± 17.6 years | Questionnaire report | PHQ-8 | 9 |
| Wang Y [87] | 2023 | USA | Cross-sectional | 4562 | 50.1 | 49.2 ± 17.6 years | Bowel Health Questionnaire | PHQ-9 | 6 |
| Werth BL [88] | 2020 | Australia | Cross-sectional | 1978 | 50.9% | 46.2 ± 16.68 years | Rome III | Clinical diagnostic | 8 |
| Yun Q [89] | 2024 | UK | Cohort | 449459 | 53.5 | 94.45 ± 9.51 years | ICD10 and Self-reported | PHQ-9 | 8 |
CSS Constipation Scoring System, GSD Geriatric Depression Scale, ROME Rome questionnaire, HADS-D The Hospital Anxiety and Depression Scale, PHQ Patient Health Questionnaire, BSFS The Bristol Stool Form Scale, ICD International Classification of Diseases, CBCL Child Behavior Check List, BDI Beck Depression Inventory, N not explicitly mentioned.
Sample sizes varied widely, ranging from 913 to 449,459 participants. The proportion of female participants ranged from approximately 45% to more than 70%, and study populations included adolescents, adults, and older adults. Across studies, constipation and depression were assessed using heterogeneous methods, including clinical diagnoses, medical records, and validated self-report instruments.
Overall, the methodological quality of the included studies was moderate to high. Newcastle–Ottawa Scale scores ranged from 5 to 9, with 16 studies achieving scores of 7 or higher, indicating generally good methodological quality (Table 2).
Table 2.
The NOS quality assessment of studies.
| Study | Year | Selection (4) | Comparability (2) | Outcome (3) | Total |
|---|---|---|---|---|---|
| Adibi P [37] | 2022 | ★★★★ | ★★ | ★★★ | 9 |
| Cheng C [74] | 2003 | ★★★ | ★★ | ★★ | 7 |
| Eustis SJ [75] | 2022 | ★★★★ | ★★ | ★★ | 8 |
| Haug TT [76] | 2002 | ★★★ | ★★ | ★★★ | 8 |
| He Z [38] | 2024 | ★★★★ | ★★ | ★★★ | 9 |
| Huang Q [77] | 2025 | ★★★★ | ★★ | ★★★ | 9 |
| Jiang B-C [78] | 2025 | ★★★★ | ★★ | ★★ | 8 |
| Kiko H [79] | 2025 | ★★ | ★ | ★★ | 5 |
| Mody R [80] | 2014 | ★★★★ | ★★ | ★★ | 8 |
| Rajindrajith S [81] | 2020 | ★★★ | ★★ | ★★ | 7 |
| Sun Z [82] | 2022 | ★★★ | ★★ | ★★ | 7 |
| Vu NTH [83] | 2024 | ★★★ | ★★ | ★★★ | 8 |
| Wang L [84] | 2024 | ★★★★ | ★★ | ★★★ | 9 |
| Wang P [85] | 2023 | ★★★★ | ★★ | ★★ | 9 |
| Wang P [86] | 2025 | ★★★★ | ★★ | ★★★ | 9 |
| Wang Y [87] | 2023 | ★★★ | ★★ | ★ | 6 |
| Werth BL [88] | 2020 | ★★★ | ★★ | ★★★ | 8 |
| Yun Q [89] | 2024 | ★★★★ | ★★ | ★★ | 8 |
Data extraction and effect measures
Multivariable-adjusted effect estimates were extracted whenever available. Of the 18 included studies, 15 reported odds ratios (ORs) directly, of which 13 provided adjusted estimates. Three studies reported alternative statistical measures, including one correlation coefficient, one standardized mean difference, and one study presenting outcomes as mean ± standard deviation. These measures were converted into ORs using the predefined transformation formulas described in Methods.
When multiple statistical models were reported within a study, the most fully adjusted estimate was selected for the primary analysis. Corresponding authors were contacted to obtain missing or additional data when necessary. To evaluate the robustness of the pooled results, sensitivity analyses were conducted by repeating the meta-analysis after excluding studies in which effect estimates had been converted to ORs.
Primary outcome: association between constipation and depression
A random-effects meta-analysis demonstrated that constipation was significantly associated with an increased risk of depression after accounting for confounding factors (OR = 2.08, 95% CI: 1.84–2.34, Fig. 2). Substantial between-study heterogeneity was observed (τ² = 0.093; I2 = 92.6%, p < 0.001), warranting further sensitivity analyses. Leave-one-out analyses showed that the exclusion of any single study did not materially alter the pooled effect estimate or its statistical significance, indicating that the observed heterogeneity was not driven by an individual study.
Fig. 2. Forest plots of the association between constipation and depression.
(A): Forest plot showing pooled odds ratios (ORs) and 95% confidence intervals (CIs) for the association between constipation and depression across included studies using a random-effects model. (B): Sensitivity analysis examining the robustness of the pooled association between constipation and depression by sequentially excluding individual studies. OR, odds ratio; CI, confidence interval.
To further characterize the expected variability of effects, a 95% prediction interval was calculated and ranged from 1.32 to 3.27. This suggests that while future studies are likely to observe a positive association between constipation and depression, the magnitude of this association may vary across different populations, settings, or study designs.
To assess the robustness of the primary findings, an additional sensitivity analysis was conducted excluding the three studies in which odds ratios were derived through statistical conversion. The association between constipation and depression remained statistically significant, with a pooled OR of 1.94 (95% CI: 1.75–2.15; Supplementary Figure 3) based on the remaining 15 studies. Although heterogeneity remained considerable, it was reduced (I² = 87.3%; τ² = 0.048; p < 0.001) compared with the primary analysis, indicating that effect size conversion contributed modestly to between-study variability but did not account for the overall association.
Potential publication bias was evaluated using funnel plots (Supplementary Figures 1, 2), which did not reveal marked asymmetry. This observation was supported by Egger’s regression test (bias coefficient = 2.09, p = 0.094), suggesting no significant evidence of small-study effects. Taken together, these findings indicate that the observed association between constipation and depression is robust across multiple analytical approaches.
Subgroup analysis
To explore potential sources of the substantial heterogeneity observed in the primary analysis (I² = 92.6%), a series of predefined subgroup analyses were conducted (Table 3). Overall, the association between constipation and depression was consistently positive across all examined subgroups, although the magnitude of the association varied according to several study-level characteristics.
Table 3.
Subgroup analysis summary of the association between constipation and depression.
| Number of studies | Number of participants | Meta-analysis | Between group p value | ||||
|---|---|---|---|---|---|---|---|
| OR | 95%CI | p value | I2 (%) | ||||
| Geographical region | 18 | 730263 | 2.08 | 1.84–2.34 | <0.001 | 92.6 | |
| Asia | 6 | 22940 | 2.28 | 1.62–3.22 | <0.001 | 95.3 | <0.001 |
| North America | 9 | 194888 | 2.22 | 1.93–2.56 | <0.001 | 76.7 | |
| Europe | 2 | 510457 | 1.48 | 1.41–1.55 | =0.837 | 0.0 | |
| Oceania | 1 | 1978 | 1.49 | 1.08–2.06 | <0.001 | - | |
| More than 50% of female | 15 | 665070 | 1.96 | 1.78–2.16 | <0.001 | 86.2 | |
| Yes | 11 | 622079 | 1.94 | 1.69–2.24 | <0.001 | 88.4 | =0.171 |
| NO | 4 | 42991 | 2.17 | 1.73–2.74 | =0.305 | 17.2 | |
| Age | 14 | 640403 | 1.97 | 1.78–2.18 | <0.001 | 87.0 | |
| Elder | 3 | 463164 | 1.64 | 1.44–1.87 | =0.002 | 84.3 | =0.009 |
| Adult | 9 | 174648 | 2.11 | 1.84–2.43 | <0.001 | 76.9 | |
| Youth | 2 | 2591 | 2.43 | 1.78–3.31 | =0.770 | 0.0 | |
| Study type | 18 | 730263 | 2.08 | 1.84–2.34 | <0.001 | 92.6 | |
| Cross-sectional | 15 | 163710 | 2.16 | 1.81–2.58 | <0.001 | 91.2 | =0.106 |
| Cohort | 3 | 566553 | 1.74 | 1.43–2.12 | <0.001 | 96.0 | |
| Sample size | 18 | 730263 | 2.08 | 1.84–2.34 | <0.001 | 92.6 | |
| Medium-small sized | 7 | 16759 | 2.39 | 1.62–3.54 | <0.001 | 94.7 | =0.018 |
| Large sized | 8 | 87631 | 2.11 | 1.87–2.37 | =0.034 | 53.7 | |
| Super large sized | 3 | 625873 | 1.59 | 1.34–1.89 | <0.001 | 96.3 | |
| Measurement of constipation | 18 | 730263 | 2.08 | 1.84–2.34 | <0.001 | 92.6 | |
| Self-report | 6 | 37722 | 2.24 | 1.78–2.82 | <0.001 | 82.2 | =0.133 |
| Standardized criteria | 6 | 27642 | 2.29 | 1.55–3.39 | <0.001 | 94.8 | |
| Medical record | 6 | 664899 | 1.76 | 1.53–2.02 | <0.001 | 92.1 | |
| Measurement of depression | 18 | 730263 | 2.08 | 1.84–2.34 | <0.001 | 92.6 | |
| Standardized scale | 14 | 162497 | 2.21 | 1.84–2.64 | <0.001 | 91.6 | =0.035 |
| Medical record | 3 | 566853 | 1.62 | 1.34–1.96 | <0.001 | 95.9 | |
| Other | 1 | 913 | 2.56 | 1.59–4.12 | <0.001 | - | |
OR odds ratio, CI confidence interval.
Stronger associations were observed in studies conducted in Asia and North America, among adolescent populations compared with adults and older adults, in studies with smaller sample sizes, and in studies that assessed depression using standardized self-report instruments. These findings suggest that demographic context, age group, study scale, and outcome assessment methods may contribute to between-study variability.
In contrast, subgroup comparisons based on study design (cross-sectional versus cohort), the proportion of female participants (>50% versus ≤50%), and the method used to assess constipation did not reveal statistically significant differences between subgroups (all p values > 0.05; Supplementary Figures 4–9). Although point estimates differed numerically across these categories, formal tests for subgroup differences were not significant. Therefore, these variations should be interpreted cautiously and should not be regarded as evidence of definitive subgroup-specific effects.
Discussion
In this systematic review and meta-analysis of 18 observational studies involving 730,263 participants, we found a robust and statistically significant association between constipation and depression in the general population, with a pooled odds ratio of 2.08. Although substantial heterogeneity was observed across studies, the direction and magnitude of the association were generally consistent, and multiple sensitivity analyses confirmed the stability of the findings. Importantly, subgroup analyses suggested that this heterogeneity was not random, but was systematically influenced by demographic and methodological factors, providing important insights into the contexts in which the association appears to be most pronounced.
First, the association between constipation and depression was strongest in studies conducted in Asia and North America and weaker in Europe and Oceania. One plausible explanation for this geographic variation relates to dietary patterns. A growing body of evidence indicates that adherence to a Mediterranean dietary pattern is associated with a lower risk of depression [43–45]. Dietary patterns differ across regions, with some Asian and North American populations tending to consume more fried, fermented, or ultra-processed foods, whereas Mediterranean diets—common in parts of Europe—emphasize olive oil, fish, nuts, legumes, and whole grains [46–51]. These regional dietary differences may partly contribute to the observed variability in the association between constipation and depressive symptoms, although direct evidence linking these patterns to the gut–brain axis in this context remains limited. These dietary characteristics may also partly contribute to regional differences in gut–brain axis function and in the co-occurrence of depressive symptoms and constipation. In addition, regional differences in symptom perception, cultural norms surrounding mental health reporting, gut microbiota composition, and healthcare-seeking behaviors may further contribute to the observed geographic variability.
Second, we observed a markedly stronger association between constipation and depression in adolescents than in adults and older adults. This age-related gradient is biologically plausible and clinically important. Adolescence and early adulthood represent critical periods for neurodevelopment, particularly for maturation of the prefrontal cortex and limbic circuitry, as well as for the establishment of stable gut–brain axis signaling [52–54]. During these vulnerable developmental windows, disturbances in gut motility, microbiota composition, visceral sensitivity, and low-grade inflammation associated with chronic constipation may influence co-occurring depressive symptoms. In contrast, depression in older adults may be influenced by a broader range of biological, psychosocial, and comorbid factors [55–58]. The observed differences in associations across age groups may reflect these developmental and study-level variations and should therefore be interpreted cautiously, rather than as implying a direct causal effect. These findings underscore the importance of awareness of co-occurring depressive symptoms in adolescents and young adults presenting with chronic constipation, which may help guide clinical assessment rather than imply a direct causal effect.
Third, methodological factors—particularly the assessment of depression—emerged as an important source of heterogeneity. Studies using standardized self-report scales reported stronger associations than those relying on medical record–based diagnoses [59, 60]. Self-report instruments are designed to capture a broad spectrum of depressive symptoms with high sensitivity and may therefore reflect overlap among somatic discomfort, emotional distress, and functional impairment directly related to constipation. In contrast, diagnoses derived from medical records typically reflect clinically confirmed depression, with greater specificity and stricter exclusion of symptoms attributable to physical illness [61, 62], resulting in more conservative effect estimates. These findings suggest that constipation is closely associated with depressive symptomatology across a continuum of severity, whereas its relationship with strictly defined clinical depression, although still significant, is more modest. Similarly, although differences in constipation assessment methods did not reach statistical significance, self-reported constipation in community surveys yielded higher point estimates than registry-based diagnoses, likely reflecting differences in symptom thresholds and case definitions.
Fourth, the observed relationship between study sample size and effect magnitude provides important context for interpreting the pooled estimates. Smaller and medium-sized studies tended to report larger effect sizes, whereas very large population-based studies yielded more conservative estimates. This pattern is consistent with the well-described small-study effect, in which studies with larger effect sizes are more likely to be published [63, 64]. Consequently, meta-analyses that include a substantial proportion of smaller studies may overestimate the true association. Large-scale cohort and registry-based studies, which are generally less susceptible to selective reporting and random error, likely provide more stable estimates; notably, these studies still demonstrated a meaningful association (OR ≈ 1.6). Additionally, cross-sectional studies, which are more vulnerable to reverse causation, reported stronger associations than cohort studies, which typically yielded more conservative estimates. Together, these findings suggest that, although the true effect size may be lower than that reported in some individual studies, the association between constipation and depression remains robust and clinically relevant.
These epidemiological observations are supported by biologically plausible mechanisms. The gut–brain axis provides a compelling framework for understanding the coexistence of constipation and depression. Disruptions in gut motility and intestinal barrier function may facilitate translocation of microbial metabolites and endotoxins into the systemic circulation, triggering immune activation and neuroinflammatory responses that influence mood and behavior [65–68]. Altered gut microbiota composition in constipation may further impair the production of neuroactive compounds, such as short-chain fatty acids and tryptophan metabolites, that are critical for brain function and emotional regulation. Conversely, depression may also affect gut function and microbiota composition through behavioral changes, altered diet, reduced physical activity, neuroendocrine dysregulation [69–71], and autonomic nervous system activity, highlighting the likely bidirectional nature of the association. In parallel, the chronic physical discomfort, bloating, pain, and reduced QOL associated with constipation may act as persistent psychological stressors that are associated with co-occurring depressive symptoms [10, 72, 73]. Taken together, these mechanisms suggest that constipation should not be viewed solely as a localized gastrointestinal disorder, but rather as a systemic condition linked to mental health outcomes through bidirectional gut–brain axis interactions.
From a translational perspective, the present findings suggest that constipation is associated with depressive symptoms, particularly in adolescents and young adults. Clinicians should be aware that patients presenting with chronic constipation may experience co-occurring depressive symptoms and should take this possibility into consideration during clinical assessment. Moreover, emerging evidence indicates that interventions targeting gut function—such as dietary modification, microbiota-directed therapies, and improvement of bowel motility— may have beneficial effects on mental health, although causality cannot be inferred from the current observational data [68, 72, 73]. These observations highlight the potential value of integrated care models that consider both gastrointestinal and mental health outcomes. Future prospective and interventional studies are warranted to examine whether effective management of constipation can influence depressive symptoms and to explore the temporal and biological pathways that may underlie this association.
This study has several strengths, including a large aggregated sample size, a comprehensive search strategy, and rigorous sensitivity and subgroup analyses. Nevertheless, several limitations merit consideration. First, the predominance of cross-sectional studies limits causal inference and highlights the possibility of bidirectional relationships between constipation and depression; depression may also contribute to constipation through behavioral, neuroendocrine, and autonomic pathways. Second, despite extensive subgroup analyses, residual heterogeneity remained high, likely reflecting substantial variability in exposure and outcome definitions across studies. Some of the residual heterogeneity may also reflect unmeasured confounding factors, including diet quality and lifestyle behaviors, which were not consistently adjusted for across studies. Furthermore, diet quality and related lifestyle factors may act as important confounders, as poor dietary patterns are associated with both constipation and depressive symptoms, particularly in adolescents. Most included studies did not adequately adjust for these factors, highlighting a limitation of the current evidence base. Third, although Egger’s test did not indicate significant publication bias, slight funnel plot asymmetry and the sample size–dependent effects suggest that selective reporting cannot be entirely excluded. Finally, language restrictions may have resulted in omission of relevant studies published in non-English journals.
Despite these limitations, this meta-analysis provides robust epidemiological evidence supporting a meaningful association between constipation and depression. Future research should prioritize well-designed prospective cohort studies, harmonized diagnostic criteria, and mechanistic investigations to better understand the temporal and biological relationships underlying this association. Such efforts may ultimately guide more informed clinical assessment and the development of integrated approaches that consider both gastrointestinal and mental health outcomes.
In conclusion, this meta-analysis demonstrates that constipation is associated with depressive symptoms, with stronger associations observed in younger populations and variability across geographic regions and assessment methods. Clinicians should be aware that patients with chronic constipation may experience co-occurring depressive symptoms, particularly adolescents and young adults, and should take this into consideration during clinical assessment. Recognizing the potential co-occurrence of constipation and psychological distress, rather than interpreting constipation solely as a gastrointestinal complaint, may support earlier identification of individuals at risk and guide appropriate clinical monitoring and care to improve long-term outcomes.
Supplementary information
Acknowledgements
ChatGPT (OpenAI) was used to enhance the readability of the manuscript.
Author contributions
KH, JJY, and GFZ conceived and designed the study. ZYR, ZYG, and QD analyzed the data. ZYR and ZYG drafted the first version of the manuscript. KH, JJY, and GFZ reviewed and edited the manuscript. All authors provided critical comments and approved the final version of the manuscript.
Funding
This study was supported by the National Natural Science Foundation of China (to JJY: 82171189, to GFZ: 82371279 and to ZYR: 82401461).
Data availability
The data that support the findings of this study are available from the corresponding authors upon reasonable request.
Competing interests
The authors declare no competing interests related to this study.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Zhuo-Yu Ren, Zi-Yi Guo.
Contributor Information
Kenji Hashimoto, Email: hashimoto@faculty.chiba-u.jp.
Jian-Jun Yang, Email: yjyangjj@126.com.
Guang-Fen Zhang, Email: wfzhgf87@126.com.
Supplementary information
The online version contains supplementary material available at 10.1038/s41398-026-04138-8.
References
- 1.Hou F, Han X, Wang Q, Zhou S, Zhang J, Shen G, et al. Cross-sectional associations between living and built environments and depression symptoms among chinese older adults. Int J Environ Res Public Health. 2022;19:5819 10.3390/ijerph19105819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204-22. 10.1016/S0140-6736(20)30925-9 [DOI] [PMC free article] [PubMed]
- 3.GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–50. 10.1016/S2215-0366(21)00395-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262:914–9. 10.1001/jama.1989.03430070062031. [PubMed] [Google Scholar]
- 5.Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–8. 10.1016/S0140-6736(07)61415-9. [DOI] [PubMed] [Google Scholar]
- 6.Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76:155–62. 10.4088/JCP.14m09298. [DOI] [PubMed] [Google Scholar]
- 7.Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582–91. 10.1038/ajg.2011.164. [DOI] [PubMed] [Google Scholar]
- 8.Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel Disorders. Gastroenterology. 2016 Feb 18:S0016-5085(16)00222-5. 10.1053/j.gastro.2016.02.031 [DOI] [PubMed]
- 9.Garrigues V, Gálvez C, Ortiz V, Ponce M, Nos P, Ponce J. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol. 2004;159:520–6. 10.1093/aje/kwh072. [DOI] [PubMed] [Google Scholar]
- 10.Wald A, Scarpignato C, Kamm MA, Mueller-Lissner S, Helfrich I, Schuijt C, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther. 2007;26:227–36. 10.1111/j.1365-2036.2007.03376.x. [DOI] [PubMed] [Google Scholar]
- 11.Tornkvist N, Palsson OS, Hreinsson J, Sperber AD, Bangdiwala SI, Törnblom H, et al. Global prevalence, characterization and impact of Functional Bowel Disorders. Am J Gastroenterol. 2025 Sep 29.10-14309. 10.14309/ajg.0000000000003782 [DOI] [PubMed]
- 12.Wang XJ, Chedid V, Vijayvargiya P, Camilleri M. Clinical features and associations of descending perineum syndrome in 300 adults with constipation in gastroenterology referral practice. Dig Dis Sci. 2020;65:3688–95. 10.1007/s10620-020-06394-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dykes S, Smilgin-Humphreys S, Bass C. Chronic idiopathic constipation: a psychological enquiry. Eur J Gastroenterol Hepatol. 2001;13:39–44. 10.1097/00042737-200101000-00007. [DOI] [PubMed] [Google Scholar]
- 14.Chang L, Wei Y, Hashimoto K. Brain-gut-microbiota axis in depression: A historical overview and future directions. Brain Res Bull. 2022;182:44–56. 10.1016/j.brainresbull.2022.02.004. [DOI] [PubMed] [Google Scholar]
- 15.Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. 2023;90:104527. 10.1016/j.ebiom.2023.104527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lachmansingh DA, Lavelle A, Cryan JF, Clarke G. Microbiota-Gut-Brain axis and antidepressant treatment. Curr Top Behav Neurosci. 2024;66:175–216. 10.1007/7854_2023_449. [DOI] [PubMed] [Google Scholar]
- 17.Ma L, Wang HB, Hashimoto K. The vagus nerve: An old but new player in brain-body communication. Brain Behav Immun. 2025;124:28–39. 10.1016/j.bbi.2024.11.023. [DOI] [PubMed] [Google Scholar]
- 18.Liu L, Wang H, Guo S, Liu S, Du Y, Wang L, et al. The emerging role of the gut microbiome in depression: implications for precision medicine. Mol Psychiatry. 2025;30:5901–13. 10.1038/s41380-025-03191-x. [DOI] [PubMed] [Google Scholar]
- 19.Green M, Trivedi MH, Foster JA. Microbes and mood: innovative biomarker approaches in depression. Trends Mol Med. 2025;31:50–63. 10.1016/j.molmed.2024.09.002. [DOI] [PubMed] [Google Scholar]
- 20.Yang L, Wang Y, Zhang Y, Li W, Jiang S, Qian D, et al. Gut microbiota: a new avenue to reveal pathological mechanisms of constipation. Appl Microbiol Biotechnol. 2022;106:6899–913. 10.1007/s00253-022-12197-2. [DOI] [PubMed] [Google Scholar]
- 21.Pan R, Wang L, Xu X, Chen Y, Wang H, Wang G, et al. Crosstalk between the gut microbiome and colonic motility in chronic constipation: potential mechanisms and microbiota modulation. Nutrients. 2022;14:3704 10.3390/nu14183704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dimidi E, Christodoulides S, Scott SM, Whelan K. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv Nutr. 2017;8:484–94. 10.3945/an.116.014407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13:701–12. 10.1038/nrn3346. [DOI] [PubMed] [Google Scholar]
- 24.Jia M, Fan Y, Ma Q, Yang D, Wang Y, He X, et al. Gut microbiota dysbiosis promotes cognitive impairment via bile acid metabolism in major depressive disorder. Transl Psychiatry. 2024;14:503. 10.1038/s41398-024-03211-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Luo K, Zhang M, Tu Q, Li J, Wang Y, Wan S, et al. From gut inflammation to psychiatric comorbidity: mechanisms and therapies for anxiety and depression in inflammatory bowel disease. J Neuroinflammation. 2025;22:149. 10.1186/s12974-025-03476-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sutoko S, Atsumori H, Obata A, Funane T, Kandori A, Shimonaga K, et al. Lesions in the right Rolandic operculum are associated with self-rating affective and apathetic depressive symptoms for post-stroke patients. Sci Rep. 2020;10:20264. 10.1038/s41598-020-77136-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Zheng J, Cai W, Lu X, He W, Li D, Zhong H, et al. Chronic stress accelerates the process of gastric precancerous lesions in rats. J Cancer. 2021;12:4121–33. 10.7150/jca.52658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002;122:1140–56. 10.1053/gast.2002.32392. [DOI] [PubMed] [Google Scholar]
- 29.Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014;264:651–60. 10.1007/s00406-014-0502-z. [DOI] [PubMed] [Google Scholar]
- 30.Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016;65:57–62. 10.1136/gutjnl-2015-309618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Parthasarathy G, Chen J, Chen X, Chia N, O’Connor HM, Wolf PG, et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology. 2016;150:367–79.e1. 10.1053/j.gastro.2015.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhu L, Liu W, Alkhouri R, Baker RD, Bard JE, Quigley EM, et al. Structural changes in the gut microbiome of constipated patients. Physiol Genomics. 2014;46:679–86. 10.1152/physiolgenomics.00082.2014. [DOI] [PubMed] [Google Scholar]
- 33.Wan M, Liu W, Liu Y, Jiang X, Jiang S, Duan J. The microbiota-gut-brain axis theory: A new perspective to unlock the pathological mechanism of constipation. Pathol Res Pract. 2025;275:156236. 10.1016/j.prp.2025.156236. [DOI] [PubMed] [Google Scholar]
- 34.Lassale C, Batty GD, Baghdadli A, Jacka F, Sánchez-Villegas A, Kivimäki M, et al. Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Mol Psychiatry. 2019;24:965–86. 10.1038/s41380-018-0237-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.O’Neil A, Quirk SE, Housden S, Brennan SL, Williams LJ, Pasco JA, et al. Relationship between diet and mental health in children and adolescents: a systematic review. Am J Public Health. 2014;104:e31–42. 10.2105/AJPH.2014.302110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yamada M, Sekine M, Tatsuse T, Fujimura Y. Lifestyle, psychological stress, and incidence of adolescent constipation: results from the Toyama birth cohort study. BMC Public Health. 2021;21:47. 10.1186/s12889-020-10044-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Adibi P, Abdoli M, Daghaghzadeh H, Keshteli AH, Afshar H, Roohafza H, et al. Relationship between depression and constipation: results from a large cross-sectional study in adults. Korean J Gastroenterol. 2022;80:77–84. 10.4166/kjg.2022.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.He Z, Yu Q, He B, Liu J, Gao W, Chen X. Can depression lead to chronic constipation, or does chronic constipation worsen depression? NHANES 2005-2010 and bidirectional mendelian randomization analyses. BMC Gastroenterol. 2024;24:361 10.1186/s12876-024-03454-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Taylor KS, Mahtani KR, Aronson JK. Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis. BMJ Evid Based Med. 2021;26:88–90. 10.1136/bmjebm-2020-111651. [DOI] [PubMed] [Google Scholar]
- 40.Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45. 10.1186/1471-2288-14-45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Friedrich JO, Adhikari NK, Beyene J. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. J Clin Epidemiol. 2011;64:556–64. 10.1016/j.jclinepi.2010.09.016. [DOI] [PubMed] [Google Scholar]
- 42.Borenstein M, Hedges L, Higgins J, Rothstein, HR (2021). Introduction to meta-analysis. John Wiley & Sons.
- 43.Roponen J, Virtanen JK, Partonen T, Absetz P, Hantunen S, Tuomainen TP, et al. Adherence to a healthy Nordic diet is associated with a lower prevalence of depressive symptoms. Br J Nutr. 2025;134:79–85. 10.1017/S0007114525103772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zhang K, Wu Y, Yi L, Wu Y, Deng Y, Xu X, et al. Adherence to the mediterranean diet and risk of depression: a cohort study in chinese community residents. Nutrients. 2025;17:942 10.3390/nu17060942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Camprodon-Boadas P, Gil-Dominguez A, De la Serna E, Sugranyes G, Lázaro I, Baeza I. Mediterranean diet and mental health in children and adolescents: a systematic review. Nutr Rev. 2025;83:e343–e355. 10.1093/nutrit/nuae053. [DOI] [PubMed] [Google Scholar]
- 46.Bach-Faig A, Berry EM, Lairon D, Reguant J, Trichopoulou A, Dernini S, et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011;14:2274–84. 10.1017/S1368980011002515. [DOI] [PubMed] [Google Scholar]
- 47.De Filippis F, Pellegrini N, Vannini L, Jeffery IB, La Storia A, Laghi L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65:1812–21. 10.1136/gutjnl-2015-309957. [DOI] [PubMed] [Google Scholar]
- 48.Zinöcker MK, Lindseth IA. The western diet-microbiome-host interaction and its role in metabolic disease. Nutrients. 2018;10:365 10.3390/nu10030365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Oddo VM, Welke L, McLeod A, Pezley L, Xia Y, Maki P, et al. Adherence to a Mediterranean Diet Is Associated with Lower Depressive Symptoms among U.S. Adults. Nutrients. 2022;14:278 10.3390/nu14020278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Lee H, Yim Y, Cho Y, Oh J, Kim S, Son Y, et al. Long-term trends and patterns in ultra-processed food consumption among Korean adults from 1998 to 2022. Sci Rep. 2025;15:4131. 10.1038/s41598-025-88489-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Hwang YG, Pae C, Lee SH, Yook KH, Park CI. Relationship between Mediterranean diet and depression in South Korea: the Korea National Health and Nutrition Examination Survey. Front Nutr. 2023;10:1219743. 10.3389/fnut.2023.1219743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Flannery J, Callaghan B, Sharpton T, Fisher P, Pfeifer J. Is adolescence the missing developmental link in Microbiome-Gut-Brain axis communication?. Dev Psychobiol. 2019;61:783–95. 10.1002/dev.21821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Casey BJ, Jones RM, Hare TA. The adolescent brain. Ann N Y Acad Sci. 2008;1124:111–26. 10.1196/annals.1440.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019;99:1877–2013. 10.1152/physrev.00018.2018. [DOI] [PubMed] [Google Scholar]
- 55.Aziz R, Steffens DC. What are the causes of late-life depression?. Psychiatr Clin North Am. 2013;36:497–516. 10.1016/j.psc.2013.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Alexopoulos GS. Depression in the elderly. Lancet. 2005;365:1961–70. 10.1016/S0140-6736(05)66665-2. [DOI] [PubMed] [Google Scholar]
- 57.Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry. 1997;54:915–22. 10.1001/archpsyc.1997.01830220033006. [DOI] [PubMed] [Google Scholar]
- 58.Cacioppo JT, Cacioppo S. Social relationships and health: the toxic effects of perceived social isolation. Soc Personal Psychol Compass. 2014;8:58–72. 10.1111/spc3.12087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Cuijpers P, van Straten A, van Schaik A, Andersson G. Psychological treatment of depression in primary care: a meta-analysis. Br J Gen Pract. 2009;59:e51–60. 10.3399/bjgp09X395139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Roseman M, Kloda LA, Saadat N, Riehm KE, Ickowicz A, Baltzer F, et al. Accuracy of depression screening tools to detect major depression in children and adolescents: a systematic review. Can J Psychiatry. 2016;61:746–57. 10.1177/0706743716651833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Thombs BD, Benedetti A, Kloda LA, Levis B, Azar M, Riehm KE, et al. Diagnostic accuracy of the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses. BMJ Open. 2016;6:e011913 10.1136/bmjopen-2016-011913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Stewart R, Davis K. Big data’ in mental health research: current status and emerging possibilities. Soc Psychiatry Psychiatr Epidemiol. 2016;51:1055–72. 10.1007/s00127-016-1266-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Lu L, Phua QS, Bacchi S, Goh R, Gupta AK, Kovoor JG, et al. Small study effects in diagnostic imaging accuracy: a meta-analysis. JAMA Netw Open. 2022;5:e2228776 10.1001/jamanetworkopen.2022.28776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ. 2010;341:c3515 10.1136/bmj.c3515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46–56. 10.1038/nrn2297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hanning N, Edwinson AL, Ceuleers H, Peters SA, De Man JG, Hassett LC, et al. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review. Therap Adv Gastroenterol. 2021;14:1756284821993586. 10.1177/1756284821993586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28:203–9. [PMC free article] [PubMed] [Google Scholar]
- 68.Moloney RD, Johnson AC, O’Mahony SM, Dinan TG, Greenwood-Van Meerveld B, Cryan JF. Stress and the microbiota-gut-brain axis in visceral pain: relevance to irritable bowel syndrome. CNS Neurosci Ther. 2016;22:102–17. 10.1111/cns.12490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Jacka FN, O’Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017;15:23. 10.1186/s12916-017-0791-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Dinan TG, Cryan JF. Gut-brain axis in 2016: Brain-gut-microbiota axis - mood, metabolism and behaviour. Nat Rev Gastroenterol Hepatol. 2017;14:69–70. 10.1038/nrgastro.2016.200. [DOI] [PubMed] [Google Scholar]
- 71.Le Morvan de Sequeira C, Hengstberger C, Enck P, Mack I. Effect of probiotics on psychiatric symptoms and central nervous system functions in human health and disease: a systematic review and meta-analysis. Nutrients. 2022;14:621 10.3390/nu14030621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011;140:761–5. 10.1053/j.gastro.2011.01.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–45. 10.1001/archinte.163.20.2433. [DOI] [PubMed] [Google Scholar]
- 74.Cheng C, Chan AO, Hui WM, Lam SK. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study. Aliment Pharmacol Ther. 2003;18:319–26. 10.1046/j.1365-2036.2003.01663.x. [DOI] [PubMed] [Google Scholar]
- 75.Eustis SJ, McCall MW, Murphy EA, Wirth MD. Association between gastrointestinal symptoms and depression in a representative sample of adults in the United States: findings from national health and nutrition examination survey (2005-2016). J Acad Consult Liaison Psychiatry. 2022;63:268–79. 10.1016/j.jaclp.2021.08.008. [DOI] [PubMed] [Google Scholar]
- 76.Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population?. Scand J Gastroenterol. 2002;37:294–8. 10.1080/003655202317284192. [DOI] [PubMed] [Google Scholar]
- 77.Huang Q, Zhou H, Yang M, Meng Y, Wang L. Dietary inflammation and socioeconomic status mediate depression-constipation link: a cross-sectional analysis of NHANES 2005-2010. Front Nutr. 2025;12:1668654. 10.3389/fnut.2025.1668654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Jiang BC, Zhang J, Yang M, Yang HD, Zhang XB. Prevalence and risk factors of depressive and anxiety symptoms and functional constipation among university students in Eastern China. World J Psychiatry. 2025;15:106451. 10.5498/wjp.v15.i6.106451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Kiko H, Asaoka D, Nomura O, Nomoto Y, Sugano K, Matsuno K, et al. Association of constipation and geriatric depressive symptoms: cross-sectional analysis using baseline data from the JUSTICE-TOKYO prospective cohort study. Diagnostics (Basel). 2025;15:1537 10.3390/diagnostics15121537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Mody R, Guérin A, Fok B, Lasch KL, Zhou Z, Wu EQ, et al. Prevalence and risk of developing comorbid conditions in patients with chronic constipation. Curr Med Res Opin. 2014;30:2505–13. 10.1185/03007995.2014.964854. [DOI] [PubMed] [Google Scholar]
- 81.Rajindrajith S, Ranathunga N, Jayawickrama N, van Dijk M, Benninga MA, Devanarayana NM. Behavioral and emotional problems in adolescents with constipation and their association with quality of life. PLoS One. 2020;15:e0239092 10.1371/journal.pone.0239092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Sun Z, Su X, Zhao X, Yao Y, Zhao Y, Zhang P, et al. Associations between constipation, overeating, and depression: A survey of Chinese oldest-old and centenarians. Heliyon. 2022;8:e12432. 10.1016/j.heliyon.2022.e12432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Vu NTH, Quach DT, Miyauchi S, Luu MN, Yoshida M, Nguyen DTN, et al. Prevalence and associated factors of chronic constipation among Japanese university students. Front Public Health. 2024;12:1258020. 10.3389/fpubh.2024.1258020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Wang L, Tian M, Sun H, Gao J, Qi W, Xu J, et al. Association between bowel movement disorders and depressive symptoms: a cross-sectional study. Front Psychiatry. 2024;15:1449948. 10.3389/fpsyt.2024.1449948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Wang P, Shen X, Wang Y, Jia X. Association between constipation and major depression in adult Americans: evidence from NHANES 2005-2010. Front Psychiatry. 2023;14:1152435. 10.3389/fpsyt.2023.1152435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Wang P, Wang Y, Li H, Gao F, Huang X, Ye Y, et al. Association of constipation with suicidal ideation among US adults and the partial mediating role of depression. Sci Rep. 2025;15:10936. 10.1038/s41598-025-95252-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Wang Y, Shen X, Wang P. Constipation is associated with depression of any severity, but not with suicidal ideation: insights from a large cross-sectional study. Int J Colorectal Dis. 2023;38:231 10.1007/s00384-023-04520-8. [DOI] [PubMed] [Google Scholar]
- 88.Werth BL, Fisher MJ, Williams KA, Pont LG. Chronic constipation in the community: a national survey of australian adults. J Wound Ostomy Continence Nurs. 2020;47:259–64. 10.1097/WON.0000000000000632. [DOI] [PubMed] [Google Scholar]
- 89.Yun Q, Wang S, Chen S, Luo H, Li B, Yip P, et al. Constipation preceding depression: a population-based cohort study. EClinicalMedicine. 2024;67:102371. 10.1016/j.eclinm.2023.102371. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data that support the findings of this study are available from the corresponding authors upon reasonable request.


